Investor NSV Investments I, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by NSV Investments I, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-03-12 13D/A VTYX / Ventyx Biosciences, Inc. 7,102,969 5,425,425
2024-06-26 13D/A VTYX / Ventyx Biosciences, Inc. 8,439,635 7,102,969
2024-03-13 13D/A VTYX / Ventyx Biosciences, Inc. 8,439,635 8,439,635
2024-03-08 13D/A VTYX / Ventyx Biosciences, Inc. 8,556,866 8,439,635
2023-07-19 13D/A VTYX / Ventyx Biosciences, Inc. 8,522,624 8,556,866
2023-07-11 13D/A VTYX / Ventyx Biosciences, Inc. 10,077,045 8,522,624
2023-04-07 13D/A VTYX / Ventyx Biosciences, Inc. 11,824,143 10,077,045
2023-03-22 13D/A VTYX / Ventyx Biosciences, Inc. 12,974,786 11,824,143
2023-03-02 13D/A VTYX / Ventyx Biosciences, Inc. 12,974,786 12,974,786
2022-12-30 13D/A VTYX / Ventyx Biosciences, Inc. 12,974,786 12,974,786
2022-12-16 13D/A VTYX / Ventyx Biosciences, Inc. 16,892,528 12,974,786
2022-09-21 13D/A VTYX / Ventyx Biosciences, Inc. 16,892,528 16,892,528
2021-10-29 13D / VENTYX BIOSCIENCES INC 16,892,528